 |
 |
|
Today is Thursday, November 20, 2008 |
|
|
When this edition of Words To Live By was originally published, the links below opened active web pages. |
|
News Headlines
Rituximab
Effective for Some Types of Relapsed Hodgkin's Lymphoma Cell Phones Last week we were told that there is
little
demonstrable link between
cell phone use and risk of cancer. This week, a researcher at Tel Aviv
University in Israel reports differently. She says her works points to a direct
correlation between length of cell phone use, side of the head usually used and
risk of developing cancer of the salivary gland. Dr. Siegal Sadetzki published her findings in the American Journal of
Epidemiology. She said because Israel was quick to adopt cell phones, the population used older
technology longer and continues to be heavy cell phone users. Read more about it
here. Blood Test
for Ovarian Cancer Finally..a reliable blood test
to detect early ovarian cancer? Researcher Gil Mor, M.D. at the Yale
School of Medicine believes he and his associates have. By using
proteomics technology, his test doesn't measure protein signatures of the tumor
itself but rather the earliest signatures of the body's reaction to the
tumor. His work is published in the February 15 issue of the journal Clinical
Cancer Research. In an email exchange with cancerpage.com, Dr. Mor says
the test achieves 99.4% specificity (less than one chance in a hundred of a
false positive) and 91.6% sensitivity ,which is significantly higher than
the the 60% sensitivity of the CA-125 blood test. The CA-125 blood test. while
touted widely on the internet, is not recommended as a screening test for
ovarian cancer because of the unreliability of its results.
Read the
release here.
The NCI Wants
To Know The National Cancer Institute, in partnership with the Lance Armstrong Foundation, is recruiting young folks
diagnosed with cancer to participate in a research study. The study tests
questions included in a research survey questionnaire about young peoples' cancers and healthcare experiences.
Participants will be compensated - that's sweet! The researchers are looking for folks who ---
In The Lab Researchers at the M.D. Anderson Cancer Center in
Houston have caught two cancer-promoting proteins working in concert to lure a
major cancer suppressor off the job and down a blind alley to destruction. The
FOXO3a protein is turned off in about 80% of breast cancers and the
scientists believe a similar mechanism is likely at play in other solid
tumors. What they've discovered is that while the first onco-protein lures the
FOXO3a out of the cell and away from its primary tumor suppressor job of DNA
repair, the second one shreds it to pieces. The discovery offers a
promising new target for cancer therapy development.
Read more about the work and the team that did it here.
Scary Salves The folks at QuackWatch.com warn against the temptation to self treat with some of the herbal remedies touted on the internet. Case in point, bloodroot salves for use against skin cancer. They can be dangerous and if you don't believe it check out some of the evidence here. (warning..not for the faint at heart!) |
|
The weekly cancerpage.com newsletter,
Words To Live By, is intended for educational purposes only.
|
![[close window]](/images/buttons/close.gif)